Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report four cases of Omenn's syndrome (OS), an autosomal recessive disease characterized by early erythrodermia, protracted diarrhea, severe infections, lymphadenopathy, hepatosplenomegaly, failure to thrive, and leukocytosis with marked eosinophilia. The immunological investigations revealed B lymphopenia with increased levels of serum
IgE
and marked
depression
of T-cell activation, not restored by the addition of exogenous interleukin 2 (IL-2). IL-2 and interferon-gamma (IFN-gamma) production in vitro were very low or absent. One patient was treated with HLA-identical bone marrow transplant with a complete remission of the clinical picture and the immunological defect. The infant died of graft versus host disease 4 months after the graft. For the remaining three infants the outcome was also fatal within the first year of life. In conclusion, OS should be considered a severe combined immunodeficiency disease with peculiar clinical, immunological, and histological findings.
...
PMID:Clinical and immunological findings in four infants with Omenn's syndrome: a form of severe combined immunodeficiency with phenotypically normal T cells, elevated IgE, and eosinophilia. 311 64
Parasite-specific
IgE
antibody response was examined in Strongyloides ratti-infected rats. The results showed that the parasite-specific
IgE
antibody response was generated after a primary infection. However, repeated infections rather depressed the level of parasite-specific
IgE
antibody in the serum. Immunization limited to specific stages of the parasite revealed that stimulation of parasite-specific
IgE
antibody was related to the intestinal adult stage. On the other hand,
depression
of
IgE
titers was related to the tissue-migrating larval stage. The capacity of the each stage of the parasite to induce specific
IgE
response may be related to the variable results of the
IgE
responses in human strongyloidiasis.
...
PMID:IgE response in Strongyloides ratti-infected rats with special reference to the life cycle of the parasite. 370 10
Alpha- and gamma-interferon (IFN) production by peripheral blood mononuclear cells (PBMC) from 18 patients affected by primary immunodeficiency syndromes was examined and compared with that of 20 normal donors. Patients included 8 with common variable immunodeficiency (CVI), 2 with congenital agammaglobulinemia, 4 with ataxia-telangiectasia, 2 with hyper-
IgE
syndrome, 1 with chronic EBV infection, 1 with combined immunodeficiency, and 1 with immunodeficiency with hyper-IgM. No spontaneous IFN production was observed in either patients and controls. Newcastle disease virus-induced alpha-IFN production was found to be normal in all patients. Gamma-IFN was induced by both galactose oxidase and staphylococcal enterotoxin (B). Gamma-interferon production was low or undetectable in patients with ataxia-telangiectasia, in immunodeficiency with hyper-IgM, and in hyper-
IgE
syndrome. No major defect of gamma-IFN was found in other types of immunodeficiency, despite the presence of occasional low producers (1 of 8 CVI patients and 1 case of congenital agammaglobulinemia). No correlation was found between IFN production and natural killer activity in individual patients. The analysis of lymphocyte subsets by monoclonal antibodies revealed gross imbalances of helper/inducer and suppressor/cytotoxic subpopulations, but no overall correlation could be established with gamma-IFN production. The observation of major defects in gamma-IFN yield only in diseases with
depression
of T cell-mediated immunity might contribute to a better understanding of the pathogenetical mechanisms in these diseases. Moreover, future studies should monitor these in vitro functions and their modifications by in vitro or in vivo manipulations.
...
PMID:Interferon production in primary immunodeficiencies. 609 14
Asthmatic subjects using oral beta-adrenergic agents had significantly lower mean serum IgG levels than asthmatics not taking beta-adrenergic agents (984 vs. 1,195 mg/dl, p less than 0.025). Corticosteroid use had the same effect (920 vs. 1,195 mg/dl, p less than 0.005). Concomitant usage of both agents was associated with further
depression
of IgG levels. These were no differences between the serum levels of IgA, IgM, IgD,
IgE
and the complement components C3 and C4 associated with the use of either or both agents. These findings suggest that beta-adrenergic agents, used in pharmacologic doses, may have an effect on the immune system.
...
PMID:Effect of beta-adrenergic agents on immunoglobulin G levels of asthmatic subjects. 612 50
The status of suppressor cells in patients with allergic rhinitis or asthma was studied. This latter group showed absent concanavalin A (ConA)-inducible suppressor cell function as measured by proliferative responses to pokeweed mitogen (PWM) and decreased function as measured by responses to phytohemagglutinin (PHA) or ConA. Patients with rhinitis showed values intermediate between normals and asthmatics. Similarly, preincubation in medium enhanced proliferative responses in normal and rhinitis patients but not in asthmatics, suggesting an absence of a short-lived suppressor cell population in the latter group. Suppressor cell function correlated negatively with log10 of serum
IgE
concentrations. Theophylline-sensitive suppressor cell numbers were slightly decreased in rhinitis patients and significantly so in asthmatics (p less than 0.01). In vitro preincubation of normal lymphocytes with aminophylline or isoproterenol (10 micrograms/ml) enhanced subsequent proliferative responses to PWM. Little enhancement was observed with cells from rhinitis patients, and actual
depression
was seen with cells from asthmatics, suggesting abnormal immunomodulatory effects of cyclic-AMP active drugs in this group of patients.
...
PMID:Suppressor cell function in respiratory allergy. Modulation by aminophylline and isoproterenol. 645 83
A status of suppressor cells in patients with atopic dermatitis was studied. As a group, they showed absent concanavalin A-inducible suppressor cell function as measured by proliferative responses to pokeweed mitogen and decreased function as measured by responses to phytohemagglutinin or concanavalin A. Similarly, preincubation in medium enhanced proliferative responses in normal donors but not in atopic dermatitis patients, suggesting an absence of a short-lived suppressor cell population in the latter group. Suppressor cell function correlated negatively with log10 of serum
IgE
concentrations. Theophylline-sensitive suppressor cell numbers were significantly decreased in atopic dermatitis patients (p less than 0.01). In vitro preincubation of normal lymphocytes with aminophylline or isoproterenol (10 microgram/ml) enhanced subsequent proliferative responses to pokeweed mitogen. In contrast, actual
depression
was seen with cells from atopic dermatitis patients, suggesting abnormal immunomodulatory effects of these drugs in the disease.
...
PMID:Abnormal suppressor cell function in atopic dermatitis. 645 54
The effect of neonatally initiated injections of anti-mu serum on immunity to reinfection with Schistosoma mansoni in the rat was investigated in vitro and in vivo. Anti-mu treatment resulting in a profound
depression
of immunoglobulin synthesis dramatically decreased immunity to reinfection assessed by worm recovery technique. Complement-dependent antibody, IgG2a antibody-eosinophil-mediated and
IgE
-macrophage cytotoxicity reactions were in parallel markedly reduced. These results show the prominent role played by antibody-dependent mechanisms in immunity to schistosomes in the rat.
...
PMID:Effect of neonatal injection of anti-mu antibodies on immunity to schistosomes (S. mansoni) in the rat. 676 87
Serum
IgE
levels were evaluated in 119 untreated and 112 treated patients with Hodgkin's disease (HD). 38 of the nonatopic untreated patients showed significantly increased (> 300 IU/ml)
IgE
concentrations. No relationship could be found between increased
IgE
levels and depressed lymphocyte response to phytohemagglutinin (PHA) or the imbalance of TM and TG lymphocyte subsets. On the other hand, the mean level of suppressor activity elicitable from cells of untreated HD patients by concanavalin A preincubation did not differ significantly from that of healthy control subjects. In contrast, in treated patients, where there was a significant reduction in the number of circulating T lymphocytes, a further
depression
of the lymphocyte response to PHA, a more marked disproportion of TM and TG cell subsets and a noticeable fall in
IgE
concentration was found. These data suggest that increased
IgE
concentrations seen in untreated patients with HD are unrelated to the T-cell defects. They also suggest that hyperproduction of
IgE
is probably not invariably a consequence of a suppressor cell deficiency.
...
PMID:Hyperproduction of IgE and T-cell dysfunction in Hodgkin's disease. 696 58
In 30 patients with systemic lupus erythematosus the number of a circulating basophils was countered in different stages of activity. An inverse correlation was found between the absolute basophils count and anti-DNA antibodies and presumptive circulating immune complexes (as judged by polyethylene glycol precipitation of serum). A positive correlation was found between the absolute basophil count and C3 or C4 levels.
IgE
on the basophil surface was determined by radioimmunoassay in 7 patients. All of them showed a significantly higher surface
IgE
number. When the count of circulating basophils was roughly normal, 5 out of the 6 patients showed a positive basophil degranulation test with native DNA. These results suggest the existence of an anti-DNA specific
IgE
in lupus patients.
Depression
of the circulating basophil count may be a useful index of lupus activity.
...
PMID:Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus. 696 64
Dialysable transfer factor (TF) was given in 10 paediatric patients with severe atopic dermatitis (AD). Ten patients with AD, matched for age and severity of disease, served as controls. Prior to the therapy with TF and at weekly intervals thereafter, T- and B-cells in the blood, PHA-stimulation, total
IgE
and specific IgG antibodies to inhalant and food antigens were determined. Therapy with TF was followed by
IgE
depression
in 8/10 patients and was most pronounced in three patients with initially high levels. Some decrease of
IgE
levels was seen in four controls also, none of them, however, fell to normal levels as was seen in two of the treated patients. Specific
IgE
levels decreased slightly, but always remained within the pathological range. T-cell counts in the blood increased in 2/10 cases as well as PHA-stimulation, B-cells counts remained within normal limits. Clinical improvement was seen in one patient, five improved slightly and four remained unchanged. Our results indicate, that transfer factor can lower total
IgE
levels in cases with atopic dermatitis. The effect is most marked in patients with high total
IgE
levels. Skin involvement, however, does not closely follow in vitro findings.
...
PMID:Influence of dialysable transfer factor on IgE concentrations in patients with atopic dermatitis. 697 79
<< Previous
1
2
3
4
5
6
7
8
Next >>